학술논문

Decreased risk of treatment failure with vedolizumab and thiopurines combined compared with vedolizumab monotherapy in Crohn's disease
Document Type
Article
Source
In: Gut. (Gut, 1 September 2022, 71(9):1781-1789)
Subject
Language
English
ISSN
14683288
00175749